VERTEX PHARMACEUTICALS INC / MA Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 288.37 | 9 | 2,595 | 26,626 | 26.6 K to 26.6 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 287.63 | 19 | 5,465 | 26,635 | 26.7 K to 26.6 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 286.07 | 27 | 7,724 | 26,654 | 26.7 K to 26.7 K (-0.10 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 283.76 | 10 | 2,838 | 26,681 | 26.7 K to 26.7 K (-0.04 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 282.74 | 4 | 1,131 | 26,691 | 26.7 K to 26.7 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 281.74 | 6 | 1,690 | 26,695 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 280.47 | 9 | 2,524 | 26,701 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 279.70 | 7 | 1,958 | 26,710 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 276.40 | 6 | 1,658 | 26,717 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 274.37 | 2 | 549 | 26,723 | 26.7 K to 26.7 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 288.38 | 9 | 2,595 | 12,738 | 12.7 K to 12.7 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 287.61 | 33 | 9,491 | 12,747 | 12.8 K to 12.7 K (-0.26 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 286.12 | 20 | 5,722 | 12,780 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 284.30 | 10 | 2,843 | 12,800 | 12.8 K to 12.8 K (-0.08 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 281.23 | 21 | 5,906 | 12,810 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 279.93 | 17 | 4,759 | 12,831 | 12.8 K to 12.8 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 276.35 | 10 | 2,764 | 12,848 | 12.9 K to 12.8 K (-0.08 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 288.04 | 47 | 13,538 | 14,932 | 15 K to 14.9 K (-0.31 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 287.00 | 14 | 4,018 | 14,979 | 15 K to 15 K (-0.09 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 285.51 | 20 | 5,710 | 14,993 | 15 K to 15 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 282.85 | 10 | 2,829 | 15,013 | 15 K to 15 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 281.81 | 20 | 5,636 | 15,023 | 15 K to 15 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 279.89 | 30 | 8,397 | 15,043 | 15.1 K to 15 K (-0.20 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 275.71 | 10 | 2,757 | 15,073 | 15.1 K to 15.1 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 288.23 | 9 | 2,594 | 26,838 | 26.8 K to 26.8 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 287.50 | 18 | 5,175 | 26,847 | 26.9 K to 26.8 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 286.27 | 9 | 2,576 | 26,865 | 26.9 K to 26.9 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 285.19 | 4 | 1,141 | 26,874 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 284.03 | 3 | 852 | 26,878 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 283.03 | 4 | 1,132 | 26,881 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 282.02 | 4 | 1,128 | 26,885 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 280.34 | 11 | 3,084 | 26,889 | 26.9 K to 26.9 K (-0.04 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 278.69 | 1 | 279 | 26,900 | 26.9 K to 26.9 K (0.00 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 276.46 | 2 | 553 | 26,901 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 275.54 | 2 | 551 | 26,903 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 273.91 | 1 | 274 | 26,905 | 26.9 K to 26.9 K (0.00 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 288.35 | 9 | 2,595 | 35,179 | 35.2 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 287.62 | 24 | 6,903 | 35,188 | 35.2 K to 35.2 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 286.41 | 21 | 6,015 | 35,212 | 35.2 K to 35.2 K (-0.06 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 285.00 | 10 | 2,850 | 35,233 | 35.2 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 283.58 | 10 | 2,836 | 35,243 | 35.3 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 280.71 | 12 | 3,369 | 35,253 | 35.3 K to 35.3 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 279.93 | 17 | 4,759 | 35,265 | 35.3 K to 35.3 K (-0.05 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 276.35 | 10 | 2,764 | 35,282 | 35.3 K to 35.3 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 288.05 | 19 | 5,473 | 28,902 | 28.9 K to 28.9 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 287.19 | 15 | 4,308 | 28,921 | 28.9 K to 28.9 K (-0.05 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 286.12 | 10 | 2,861 | 28,936 | 28.9 K to 28.9 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 284.98 | 5 | 1,425 | 28,946 | 29 K to 28.9 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 283.74 | 3 | 851 | 28,951 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 282.77 | 6 | 1,697 | 28,954 | 29 K to 29 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 281.55 | 4 | 1,126 | 28,960 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 280.47 | 9 | 2,524 | 28,964 | 29 K to 29 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 279.48 | 5 | 1,397 | 28,973 | 29 K to 29 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 276.44 | 4 | 1,106 | 28,978 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 274.98 | 2 | 550 | 28,982 | 29 K to 29 K (-0.01 %) |
May 14 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 187.53 | 1,304 | 244,539 | 14,338 | |
May 14 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 287.33 | 1,304 | 374,678 | 28,902 | 30.2 K to 28.9 K (-4.32 %) |
May 14 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 187.53 | 1,304 | 244,539 | 30,206 | 28.9 K to 30.2 K (+4.51 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 10,665 | 1,406,607 | 0 | |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 286.72 | 100 | 28,672 | 35,103 | 35.2 K to 35.1 K (-0.28 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 285.94 | 1,367 | 390,880 | 35,203 | 36.6 K to 35.2 K (-3.74 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 285.15 | 2,314 | 659,837 | 36,570 | 38.9 K to 36.6 K (-5.95 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 283.98 | 1,100 | 312,378 | 38,884 | 40 K to 38.9 K (-2.75 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 282.89 | 913 | 258,279 | 39,984 | 40.9 K to 40 K (-2.23 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 281.74 | 1,398 | 393,873 | 40,897 | 42.3 K to 40.9 K (-3.31 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 280.77 | 1,817 | 510,159 | 42,295 | 44.1 K to 42.3 K (-4.12 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 279.67 | 655 | 183,184 | 44,112 | 44.8 K to 44.1 K (-1.46 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 277.38 | 201 | 55,753 | 44,767 | 45 K to 44.8 K (-0.45 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 276.25 | 800 | 221,000 | 44,968 | 45.8 K to 45 K (-1.75 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 10,665 | 1,406,607 | 45,768 | 35.1 K to 45.8 K (+30.38 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 187.53 | 1,304 | 244,539 | 14,338 | |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 286.00 | 1,304 | 372,944 | 26,838 | 28.1 K to 26.8 K (-4.63 %) |
May 13 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 187.53 | 1,304 | 244,539 | 28,142 | 26.8 K to 28.1 K (+4.86 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 155.57 | 407 | 63,317 | 2,854 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Option Exercise | M | 187.53 | 559 | 104,829 | 6,145 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 275.30 | 30 | 8,259 | 12,738 | 12.8 K to 12.7 K (-0.23 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 274.13 | 330 | 90,463 | 12,768 | 13.1 K to 12.8 K (-2.52 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 273.15 | 210 | 57,362 | 13,098 | 13.3 K to 13.1 K (-1.58 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 272.09 | 217 | 59,044 | 13,308 | 13.5 K to 13.3 K (-1.60 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 270.19 | 136 | 36,746 | 13,525 | 13.7 K to 13.5 K (-1.00 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 268.80 | 43 | 11,558 | 13,661 | 13.7 K to 13.7 K (-0.31 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 155.57 | 407 | 63,317 | 13,704 | 13.3 K to 13.7 K (+3.06 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Buy | M | 187.53 | 559 | 104,829 | 13,297 | 12.7 K to 13.3 K (+4.39 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 155.57 | 611 | 95,053 | 4,281 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 187.53 | 465 | 87,201 | 5,122 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 275.17 | 70 | 19,262 | 14,932 | 15 K to 14.9 K (-0.47 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 274.41 | 210 | 57,626 | 15,002 | 15.2 K to 15 K (-1.38 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 273.53 | 240 | 65,647 | 15,212 | 15.5 K to 15.2 K (-1.55 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 272.40 | 328 | 89,347 | 15,452 | 15.8 K to 15.5 K (-2.08 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 270.51 | 149 | 40,306 | 15,780 | 15.9 K to 15.8 K (-0.94 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 269.41 | 79 | 21,283 | 15,929 | 16 K to 15.9 K (-0.49 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 155.57 | 611 | 95,053 | 16,008 | 15.4 K to 16 K (+3.97 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 187.53 | 465 | 87,201 | 15,397 | 14.9 K to 15.4 K (+3.11 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 81.54 | 22,500 | 1,834,650 | 0 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 59.55 | 22,500 | 1,339,875 | 0 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 272.46 | 2,960 | 806,482 | 11,210 | 14.2 K to 11.2 K (-20.89 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 271.63 | 6,232 | 1,692,798 | 14,170 | 20.4 K to 14.2 K (-30.55 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 270.49 | 5,889 | 1,592,916 | 20,402 | 26.3 K to 20.4 K (-22.40 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 269.53 | 15,751 | 4,245,367 | 26,291 | 42 K to 26.3 K (-37.46 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 268.65 | 11,568 | 3,107,743 | 42,042 | 53.6 K to 42 K (-21.58 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 267.50 | 2,600 | 695,500 | 53,610 | 56.2 K to 53.6 K (-4.63 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 81.54 | 22,500 | 1,834,650 | 56,210 | 33.7 K to 56.2 K (+66.75 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 59.55 | 22,500 | 1,339,875 | 33,710 | 11.2 K to 33.7 K (+200.71 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 669 | 88,234 | 10,665 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 275.28 | 669 | 184,162 | 35,103 | 35.8 K to 35.1 K (-1.87 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 669 | 88,234 | 35,772 | 35.1 K to 35.8 K (+1.91 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 155.57 | 1,222 | 190,107 | 8,561 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 274.73 | 70 | 19,231 | 26,838 | 26.9 K to 26.8 K (-0.26 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 273.96 | 420 | 115,063 | 26,908 | 27.3 K to 26.9 K (-1.54 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 273.00 | 319 | 87,087 | 27,328 | 27.6 K to 27.3 K (-1.15 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 271.64 | 140 | 38,030 | 27,647 | 27.8 K to 27.6 K (-0.50 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 270.16 | 273 | 73,754 | 27,787 | 28.1 K to 27.8 K (-0.97 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 155.57 | 1,222 | 190,107 | 28,060 | 26.8 K to 28.1 K (+4.55 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 155.57 | 24,349 | 3,787,974 | 24,348 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 91.05 | 4,470 | 406,994 | 98,336 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 96.87 | 35,499 | 3,438,788 | 35,499 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Option Exercise | M | 187.53 | 24,216 | 4,541,226 | 24,215 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 272.41 | 5,607 | 1,527,403 | 40,821 | 46.4 K to 40.8 K (-12.08 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 271.61 | 14,131 | 3,838,121 | 46,428 | 60.6 K to 46.4 K (-23.33 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 270.43 | 13,885 | 3,754,921 | 60,559 | 74.4 K to 60.6 K (-18.65 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 269.52 | 30,237 | 8,149,476 | 74,444 | 104.7 K to 74.4 K (-28.88 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 268.63 | 24,617 | 6,612,865 | 104,681 | 129.3 K to 104.7 K (-19.04 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Sell | S | 267.52 | 5,892 | 1,576,228 | 129,298 | 135.2 K to 129.3 K (-4.36 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 155.57 | 24,349 | 3,787,974 | 135,190 | 110.8 K to 135.2 K (+21.97 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 91.05 | 4,470 | 406,994 | 110,841 | 106.4 K to 110.8 K (+4.20 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 96.87 | 35,499 | 3,438,788 | 106,371 | 70.9 K to 106.4 K (+50.09 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | Executive Chairman | Buy | M | 187.53 | 24,216 | 4,541,226 | 70,872 | 46.7 K to 70.9 K (+51.90 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 155.57 | 510 | 79,341 | 3,567 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 187.53 | 1,564 | 293,297 | 17,206 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 275.17 | 134 | 36,873 | 26,626 | 26.8 K to 26.6 K (-0.50 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 274.04 | 864 | 236,771 | 26,760 | 27.6 K to 26.8 K (-3.13 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 272.77 | 360 | 98,197 | 27,624 | 28 K to 27.6 K (-1.29 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 271.92 | 300 | 81,576 | 27,984 | 28.3 K to 28 K (-1.06 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 270.35 | 416 | 112,466 | 28,284 | 28.7 K to 28.3 K (-1.45 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 155.57 | 510 | 79,341 | 28,700 | 28.2 K to 28.7 K (+1.81 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 187.53 | 1,564 | 293,297 | 28,190 | 26.6 K to 28.2 K (+5.87 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 155.57 | 1,222 | 190,107 | 8,561 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 274.35 | 280 | 76,818 | 28,902 | 29.2 K to 28.9 K (-0.96 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 273.45 | 461 | 126,060 | 29,182 | 29.6 K to 29.2 K (-1.56 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 271.87 | 210 | 57,093 | 29,643 | 29.9 K to 29.6 K (-0.70 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 270.20 | 271 | 73,224 | 29,853 | 30.1 K to 29.9 K (-0.90 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 155.57 | 1,222 | 190,107 | 30,124 | 28.9 K to 30.1 K (+4.23 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 13,356 | 1,761,523 | 11,334 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 13,356 | 1,761,523 | 11,334 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 5,825 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 86.52 | 1,942 | 168,022 | 5,825 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 9,310 | 1,227,896 | 24,690 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 131.89 | 9,310 | 1,227,896 | 24,690 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 32,500 | 3,547,050 | 0 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 32,500 | 3,547,050 | 0 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 273.59 | 200 | 54,718 | 35,103 | 35.3 K to 35.1 K (-0.57 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 273.59 | 200 | 54,718 | 35,103 | 35.3 K to 35.1 K (-0.57 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 272.58 | 403 | 109,850 | 35,303 | 35.7 K to 35.3 K (-1.13 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 272.58 | 403 | 109,850 | 35,303 | 35.7 K to 35.3 K (-1.13 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 271.09 | 100 | 27,109 | 35,706 | 35.8 K to 35.7 K (-0.28 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 271.09 | 100 | 27,109 | 35,706 | 35.8 K to 35.7 K (-0.28 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 270.01 | 11,553 | 3,119,426 | 35,806 | 47.4 K to 35.8 K (-24.39 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 270.01 | 11,553 | 3,119,426 | 35,806 | 47.4 K to 35.8 K (-24.39 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 269.08 | 700 | 188,356 | 47,359 | 48.1 K to 47.4 K (-1.46 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 269.08 | 700 | 188,356 | 47,359 | 48.1 K to 47.4 K (-1.46 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 267.34 | 300 | 80,202 | 48,059 | 48.4 K to 48.1 K (-0.62 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 267.34 | 300 | 80,202 | 48,059 | 48.4 K to 48.1 K (-0.62 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 265.72 | 100 | 26,572 | 48,359 | 48.5 K to 48.4 K (-0.21 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 265.72 | 100 | 26,572 | 48,359 | 48.5 K to 48.4 K (-0.21 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 13,356 | 1,761,523 | 48,459 | 35.1 K to 48.5 K (+38.05 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 13,356 | 1,761,523 | 48,459 | 35.1 K to 48.5 K (+38.05 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 264.92 | 12,940 | 3,428,065 | 35,103 | 48 K to 35.1 K (-26.93 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 264.92 | 12,940 | 3,428,065 | 35,103 | 48 K to 35.1 K (-26.93 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 263.58 | 964 | 254,091 | 48,043 | 49 K to 48 K (-1.97 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 263.58 | 964 | 254,091 | 48,043 | 49 K to 48 K (-1.97 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 262.69 | 9,447 | 2,481,632 | 49,007 | 58.5 K to 49 K (-16.16 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 262.69 | 9,447 | 2,481,632 | 49,007 | 58.5 K to 49 K (-16.16 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 261.68 | 4,395 | 1,150,084 | 58,454 | 62.8 K to 58.5 K (-6.99 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 261.68 | 4,395 | 1,150,084 | 58,454 | 62.8 K to 58.5 K (-6.99 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 260.48 | 8,383 | 2,183,604 | 62,849 | 71.2 K to 62.8 K (-11.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 260.48 | 8,383 | 2,183,604 | 62,849 | 71.2 K to 62.8 K (-11.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 259.63 | 6,223 | 1,615,677 | 71,232 | 77.5 K to 71.2 K (-8.03 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 259.63 | 6,223 | 1,615,677 | 71,232 | 77.5 K to 71.2 K (-8.03 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 258.59 | 1,400 | 362,026 | 77,455 | 78.9 K to 77.5 K (-1.78 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 258.59 | 1,400 | 362,026 | 77,455 | 78.9 K to 77.5 K (-1.78 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 78,855 | 76.9 K to 78.9 K (+2.52 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 86.52 | 1,942 | 168,022 | 78,855 | 76.9 K to 78.9 K (+2.52 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 9,310 | 1,227,896 | 76,913 | 67.6 K to 76.9 K (+13.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 131.89 | 9,310 | 1,227,896 | 76,913 | 67.6 K to 76.9 K (+13.77 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 32,500 | 3,547,050 | 67,603 | 35.1 K to 67.6 K (+92.58 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 32,500 | 3,547,050 | 67,603 | 35.1 K to 67.6 K (+92.58 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 4,660 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 264.89 | 113 | 29,933 | 35,179 | 35.3 K to 35.2 K (-0.32 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 262.54 | 240 | 63,010 | 35,292 | 35.5 K to 35.3 K (-0.68 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 261.34 | 240 | 62,722 | 35,532 | 35.8 K to 35.5 K (-0.67 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 260.32 | 320 | 83,302 | 35,772 | 36.1 K to 35.8 K (-0.89 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 259.36 | 640 | 165,990 | 36,092 | 36.7 K to 36.1 K (-1.74 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Buy | M | 86.52 | 1,553 | 134,366 | 36,732 | 35.2 K to 36.7 K (+4.41 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 86.52 | 809 | 69,995 | 2,427 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 264.75 | 59 | 15,620 | 14,932 | 15 K to 14.9 K (-0.39 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 262.83 | 100 | 26,283 | 14,991 | 15.1 K to 15 K (-0.66 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 261.55 | 200 | 52,310 | 15,091 | 15.3 K to 15.1 K (-1.31 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 259.97 | 250 | 64,993 | 15,291 | 15.5 K to 15.3 K (-1.61 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 259.21 | 200 | 51,842 | 15,541 | 15.7 K to 15.5 K (-1.27 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 86.52 | 809 | 69,995 | 15,741 | 14.9 K to 15.7 K (+5.42 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 6,990 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 264.82 | 181 | 47,932 | 26,838 | 27 K to 26.8 K (-0.67 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 262.48 | 554 | 145,414 | 27,019 | 27.6 K to 27 K (-2.01 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 261.21 | 195 | 50,936 | 27,573 | 27.8 K to 27.6 K (-0.70 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 260.16 | 700 | 182,112 | 27,768 | 28.5 K to 27.8 K (-2.46 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 259.19 | 700 | 181,433 | 28,468 | 29.2 K to 28.5 K (-2.40 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 2,330 | 201,592 | 29,168 | 26.8 K to 29.2 K (+8.68 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 6,990 | |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 264.78 | 193 | 51,103 | 28,902 | 29.1 K to 28.9 K (-0.66 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 262.45 | 500 | 131,225 | 29,095 | 29.6 K to 29.1 K (-1.69 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 261.31 | 237 | 61,930 | 29,595 | 29.8 K to 29.6 K (-0.79 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 260.17 | 700 | 182,119 | 29,832 | 30.5 K to 29.8 K (-2.29 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 259.18 | 700 | 181,426 | 30,532 | 31.2 K to 30.5 K (-2.24 %) |
May 06 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 2,330 | 201,592 | 31,232 | 28.9 K to 31.2 K (+8.06 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Payment of Exercise | F | 251.78 | 547 | 137,724 | 16,727 | 17.3 K to 16.7 K (-3.17 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 90.29 | 2,125 | 191,866 | 2,125 | |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 258.15 | 100 | 25,815 | 26,838 | 26.9 K to 26.8 K (-0.37 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 256.63 | 500 | 128,315 | 26,938 | 27.4 K to 26.9 K (-1.82 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 255.44 | 680 | 173,699 | 27,438 | 28.1 K to 27.4 K (-2.42 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 254.20 | 400 | 101,680 | 28,118 | 28.5 K to 28.1 K (-1.40 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 252.70 | 300 | 75,810 | 28,518 | 28.8 K to 28.5 K (-1.04 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 251.38 | 145 | 36,450 | 28,818 | 29 K to 28.8 K (-0.50 %) |
May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 90.29 | 2,125 | 191,866 | 28,963 | 26.8 K to 29 K (+7.92 %) |